|
| Product Name: | McMMAE | | Synonyms: | Mc MMAE;McMMAE;Mc-MMAE;37: PN: WO2007140371 PAGE: 273 claimed sequence;Maleimidocaproyl-monomethylauristatin E;L-Valinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-;Mc-MMAE,Inhibitor,Drug-Linker Conjugates for ADC,McMMAE,Microtubule/Tubulin,Mc MMAE,inhibit | | CAS: | 863971-24-8 | | MF: | C49H78N6O10 | | MW: | 911.18 | | EINECS: | | | Product Categories: | ADCs;ADC LINKER | | Mol File: | 863971-24-8.mol |  |
| | McMMAE Chemical Properties |
| Boiling point | 1025.2±65.0 °C(Predicted) | | density | 1.144±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C,unstable in solution, ready to use. | | solubility | DMSO: ≥ 51 mg/mL (55.97 mM) | | pka | 13.63±0.46(Predicted) | | form | Powder |
| | McMMAE Usage And Synthesis |
| | McMMAE Preparation Products And Raw materials |
|
